N/A N=511 IVR-Enhanced Care Transition Support for Complex Patients
Congestive Heart Failure · Chronic Obstructive Pulmonary Disease
Primary: Re-hospitalizations — 27; 26; 8; 14 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=252 Problem-Solving Skills Training to Improve Care for Children With Asthma
Asthma
Primary: Parent Proxy-Reported Health-related Quality of Life (Pediatric Quality of Life Inventory) — 81.2; 85.4; 80.8 units on a scale — p=0.05
Phase 2 N=106 Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Cervical Cancer · Endometrial Cancer
Primary: Reproducibility of Radiation Technique (Number of Unacceptable Deviations in Central IMRT Quality Assurance Review) — 1; 0 participants
N/A N=31 Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Cutaneous Lupus Erythematosus
Primary: Percentage of Subjects Who Correctly Answered a Knowledge Assessment Item Immediately Before and After an Educational Lecture — 52; 94; 19; 90 percentage of participants
Phase 4 N=195 Dose Response of a Tubule Occlusion Agent
Dentine Hypersensitivity · Dental Pain
Primary: Adjusted Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Visual Analog Scale (VAS) at Day 15 — -26.1; -28.4; -26.2 Units on a scale — p=0.3628
Phase 3 N=675 The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
Diabetes Mellitus, Type 2
Primary: Change in HbA1c From Baseline to Week 26 (Main Study) — 0.14; -0.77; -1.03 Percent — p=<0.001
Phase 2 N=12 Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...
Skin Cancer · Melanoma · Metastatic Melanoma
Primary: Response Rate — 0; 0; 1; 1 Participants
N/A N=197 Foley Bulb Traction for Cervical Ripening
Cervical Ripening · Induction of Labor
Primary: Time to Delivery — 19.8; 18.8 hours
N/A N=30 Effects of Massage Therapy to Induce Sleep in Preterm Infants
Premature Birth of Newborn
Primary: Quality of Sleep, Defined by Number and Duration of Awakenings, and Longest Sustained Sleep Period for the Study Interval. These Data Were Measured by the Actigraph…
Phase 2 N=50 External Trigeminal Nerve Stimulation for Epilepsy
Epilepsy · Seizure Disorders
Primary: 50% Responder Rate — 40.5; 15.6 percentage of participants
Phase 3 N=186 Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Breast Cancer · Melanoma
Primary: Concordance of Blue Dye and Lymphoseek — 0.9767 Proportion of Lymph Nodes
Phase 3 N=305 Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy
Diabetes Mellitus, Type 2
Primary: HbA1c Change From Baseline at Week 24 — -0.14; -0.66 Percent — p=<0.0001
N/A N=12 Study of Mattress Type in Fibromyalgia
Fibromyalgia
Primary: Mattress Preference of Fibromyalgia Patients — 45; 55; 0 percentage of study participants — p=>0.1
Phase 4 N=71 An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
Pulmonary Fungal Infection
Primary: Number of Participants With Clinical Efficacy — 8; 29; 18; 5 participants
Phase 3 N=212 Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Spinal Cord Injury · Muscle Spasticity
Primary: Double-blind Change From Baseline in Ashworth Score Evaluating Spasticity — -0.19; -0.15 units on a scale